We’re NIH funded!

It’s official; NIAID (National Institute of Allergy and Infectious Disease) has funded our R21 grant “Disruption of gene function in Naegleria.” Over the next two years, we will adapt RNAi and CRISPR methods for use with Naegleria gruberi, a noninfectious relative of the deadly opportunistic pathogen Naegleria fowleri. These tools will transform basic research into the evolution and function of the eukaryotic cytoskeleton, and will lay the groundwork for understanding how Naegleria fowleri destroys brain tissues. For more details on this project, check out the summary on the NIH Reporter.